Next-generation antibody–drug conjugates revolutionize the precise classification and treatment of HER2-expressing breast cancer

Affiliations

Lei-Jie Dai: Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
Yu-Wei Li: Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
Ding Ma: Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
Zhi-Ming Shao: Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
Yi-Zhou Jiang: Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China

Abstract

No abstracts available.

ISSN: 2095-3941 (Print)
Publisher: China Anti-Cancer Association
Country of publisher: China
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.cancerbiomed.org/